Nanoparticle technologies for cancer therapy

Frank Alexis, Eric M. Pridgen, Robert Langer, Omid C. Farokhzad

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

332 Citas (Scopus)

Resumen

Nanoparticles as drug delivery systems enable unique approaches for cancer treatment. Over the last two decades, a large number of nanoparticle delivery systems have been developed for cancer therapy, including organic and inorganic materials. Many liposomal, polymer-drug conjugates, and micellar formulations are part of the state of the art in the clinics, and an even greater number of nanoparticle platforms are currently in the preclinical stages of development. More recently developed nanoparticles are demonstrating the potential sophistication of these delivery systems by incorporating multifunctional capabilities and targeting strategies in an effort to increase the efficacy of these systems against the most difficult cancer challenges, including drug resistance and metastatic disease. In this chapter, we will review the available preclinical and clinical nanoparticle technology platforms and their impact for cancer therapy.

Idioma originalInglés
Páginas (desde-hasta)55-86
Número de páginas32
PublicaciónHandbook of Experimental Pharmacology
Volumen197
DOI
EstadoPublicada - 2010
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Nanoparticle technologies for cancer therapy'. En conjunto forman una huella única.

Citar esto